EUVIMEDEUVIMED entdecken
Crossref

Fasting blood glucose as a screening measure for late‐onset gestational diabetes in the third trimester

Xiaoxia Tang iD, Jin Wei, Shaohua Wu, Sufang Wu

BJOG: An International Journal of Obstetrics & Gynaecology · 2024-11 · 131 (12) · 1715-1724

DOI: 10.1111/1471-0528.17897 ↗

Kurz gefasst

Fachartikel in der Zeitschrift BJOG: An International Journal of Obstetrics & Gynaecology, online erschienen am 02.07.2024. Verfasst von Xiaoxia Tang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Shanghai General Hospital of Nanjing Medical University, Shanghai, China. Hauptthemen laut MEDLINE: Diabetes, Gestational, Blood Glucose, Fasting, Pregnancy Trimester, Third. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 33 Literaturangaben. Gefördert von: Research Foundation of The Affiliated Taizhou People's Hospital of Nanjing Medical University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To investigate the positive rate of late‐onset gestational diabetes mellitus (GDM) by additional fasting blood glucose (FBG) screening at 32–34 gestational weeks (GW) and analyse the perinatal outcomes of late‐onset GDM after standard treatment.

Design

An Prospective cohort study.

Setting

Single centre in China. Population 1130 singleton pregnancies with negative GDM screening in their first and second trimester.

Methods

Additional FBG testing was performed at 32–34 GW. Pregnancies with FBG ≥5.1 mmol/L were diagnosed as GDM and received standardized treatment. Perinatal outcomes were collected and compared. Main Outcome Measures Diagnosis of late‐onset GDM, obstetric and neonatal outcomes.

Results

6.3% (71/1130) of participants had FBG values ≥5.1 mmol/L and were diagnosed with late‐onset GDM. Sixty‐five (91.5%) were treated by dietary therapy and 6 (8.5%) by insulin therapy. The perinatal outcomes of full‐term delivery were compared. The incidence of macrosomia (22.7% vs. 5.1%, adjusted odds ratio (aOR) 5.51, 95% confidence interval (CI) 1.83–16.61, p = 0.002) and NICU transferring (18.3% vs. 10.1%, aOR 1.94, 95% CI 1.01–3.74, p = 0.046) was significantly higher in late‐onset GDM group than that in FBG

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes, GestationalBlood GlucoseFastingPregnancy Trimester, ThirdHumansFemalePregnancyAdultProspective StudiesChinaPregnancy OutcomeMass ScreeningFetal MacrosomiaGlucose Tolerance Test

Stichwörter der Autor:innen

fasting blood glucosegestational diabetes mellitusmacrosomiathird trimester

Substanzen

Blood Glucose

Autor:innen und Institutionen

  • Shanghai General Hospital of Nanjing Medical University, Shanghai, China.
  • The Affiliated Taizhou People's Hospital of Nanjing Medical University, Taizhou, Jiangsu, China.

ORCID-Profile: Xiaoxia Tang

Förderung

  • Research Foundation of The Affiliated Taizhou People's Hospital of Nanjing Medical University

Zitieren

APA

Tang, X., Wei, J., Wu, S., & Wu, S. (2024). Fasting blood glucose as a screening measure for late‐onset gestational diabetes in the third trimester. BJOG: An International Journal of Obstetrics & Gynaecology, 131(12), 1715-1724. https://doi.org/10.1111/1471-0528.17897

Vancouver

Tang X, Wei J, Wu S, Wu S. Fasting blood glucose as a screening measure for late‐onset gestational diabetes in the third trimester. BJOG: An International Journal of Obstetrics & Gynaecology. 2024;131(12):1715-1724. doi:10.1111/1471-0528.17897

BibTeX
@article{Tang2024,
  author = {Tang, Xiaoxia and Wei, Jin and Wu, Shaohua and Wu, Sufang},
  title = {Fasting blood glucose as a screening measure for late‐onset gestational diabetes in the third trimester},
  journal = {BJOG: An International Journal of Obstetrics & Gynaecology},
  year = {2024},
  volume = {131},
  number = {12},
  pages = {1715--1724},
  doi = {10.1111/1471-0528.17897}
}
Kostenlos starten →